Collection 3 (Sep 2022 - Aug 2023) Articles

Articles
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias
Tokgozoglu L, Orringer C, Catapano A
Journal:
Eur Heart J

First published: January 2, 2023 DOI: 10.1093/eurheartj/ehac750
View
- Share
Articles
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
Sherratt SCR, Libby P, Budoff MJ, et al.
Journal:
Curr Atheroscler Rep

First published: December 29, 2022 DOI: 10.1007/s11883-022-01075-x
View
- Share
Articles
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial
Lee YJ, Cho JY, You SC, et al.
Journal:
Eur Heart J

First published: December 19, 2022 DOI: 10.1093/eurheartj/ehac709
View
- Share
Articles
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
Marx N, Husain M, Lehrke M, et al.
Journal:
Circulation

First published: December 12, 2022 DOI: 10.1161/CIRCULATIONAHA.122.059595
View
- Share
Articles
Early initiation of PCSK9 inhibition in myocardial infarction could be EPIC for patient care
Bhatt DL
Journal:
EuroIntervention

First published: December 2, 2022 DOI: 10.4244/EIJ-E-22-00047
View
- Share
Articles
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial
Mehta SR, Pare G, Lonn EM, et al.
Journal:
EuroIntervention

First published: December 2, 2022 DOI: 10.4244/EIJ-D-22-00735
View
- Share
Articles
Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial
Adusumalli S, Kanter GP, Small DS, et al.
Journal:
JAMA Cardiol

First published: November 30, 2022 DOI: 10.1001/jamacardio.2022.4373
View
- Share
Articles
Knowledge of HbA1c and LDL-C treatment goals, subjective level of disease-related information and information needs in patients with atherosclerotic cardiovascular disease
Brockmeyer M, Wies E, Joerges J, et al.
Journal:
Clin Cardiol

First published: November 30, 2022 DOI: 10.1002/clc.23948
View
- Share
Articles
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
O’Donoghue ML, Rosenson RS, Gencer B, et al.
Journal:
N Engl J Med

First published: November 17, 2022 DOI: 10.1056/NEJMoa2211023
View
- Share
Articles
New Trends and Therapies for Familial Hypercholesterolemia
Alnouri F, Santos RD
Journal:
J Clin Med

First published: November 9, 2022 DOI: 10.3390/jcm11226638
View
- Share
Articles
Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)
Sandhu AT, Rodriguez F, Ngo S, et al.
Journal:
Circulation

First published: November 7, 2022 DOI: 10.1161/CIRCULATIONAHA.122.062746
View
- Share
Articles
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
Das Pradhan A, Glynn RJ, Fruchart JC, et al.
Journal:
NEJM

First published: November 5, 2022 DOI: 10.1056/NEJMoa2210645
View
- Share

1 … 3 4 5 6 7 8

Collection 3 (Sep 2022 - Aug 2023) Articles

Articles

The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias

Tokgozoglu L, Orringer C, Catapano A

Articles

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

Sherratt SCR, Libby P, Budoff MJ, et al.

Articles

Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial

Lee YJ, Cho JY, You SC, et al.

Articles

GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes

Marx N, Husain M, Lehrke M, et al.

Articles

Early initiation of PCSK9 inhibition in myocardial infarction could be EPIC for patient care

Bhatt DL

Articles

Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial

Mehta SR, Pare G, Lonn EM, et al.

Articles

Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial

Adusumalli S, Kanter GP, Small DS, et al.

Articles

Knowledge of HbA1c and LDL-C treatment goals, subjective level of disease-related information and information needs in patients with atherosclerotic cardiovascular disease

Brockmeyer M, Wies E, Joerges J, et al.

Articles

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

O’Donoghue ML, Rosenson RS, Gencer B, et al.

Articles

New Trends and Therapies for Familial Hypercholesterolemia

Alnouri F, Santos RD

Articles

Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)

Sandhu AT, Rodriguez F, Ngo S, et al.

Articles

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Das Pradhan A, Glynn RJ, Fruchart JC, et al.

Articles

The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias

Tokgozoglu L, Orringer C, Catapano A

Share

Articles

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

Sherratt SCR, Libby P, Budoff MJ, et al.

Share

Articles

Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial

Lee YJ, Cho JY, You SC, et al.

Share

Articles

GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes

Marx N, Husain M, Lehrke M, et al.

Share

Articles

Early initiation of PCSK9 inhibition in myocardial infarction could be EPIC for patient care

Bhatt DL

Share

Articles

Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial

Mehta SR, Pare G, Lonn EM, et al.

Share

Articles

Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial

Adusumalli S, Kanter GP, Small DS, et al.

Share

Articles

Knowledge of HbA1c and LDL-C treatment goals, subjective level of disease-related information and information needs in patients with atherosclerotic cardiovascular disease

Brockmeyer M, Wies E, Joerges J, et al.

Share

Articles

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

O’Donoghue ML, Rosenson RS, Gencer B, et al.

Share

Articles

New Trends and Therapies for Familial Hypercholesterolemia

Alnouri F, Santos RD

Share

Articles

Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)

Sandhu AT, Rodriguez F, Ngo S, et al.

Share

Articles

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Das Pradhan A, Glynn RJ, Fruchart JC, et al.

Share